TLR9 and abortion: Therefore, this study aimed to determine whether inhibition of TLR9 activity via administering the antagonist ODN 2088 at the time of conception could modulate immune regulation and improve pregnancy outcomes in the murine abortion-prone model CBA/J × DBA/2J.